Kintor Pharmaceutical : Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

Suzhou, April 14, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has... | April 14, 2023

Related Keywords

Huashan ,Henan ,China ,Suzhou ,Jiangsu ,Chinese ,Yang Qinping ,Kintor Pharma ,Fudan University ,Kintor Pharmaceutical Limited Pharma ,Pharmaceutical Limited ,Huashan Hospital ,Chinese Androgenetic ,Youzhi Tong ,Chief Executive Officer ,Kintor Pharmaceutical Limited Stock Exchange ,News ,Information ,Press Release ,Pril ,023 ,Pintor ,Harmaceutical ,Imited ,Biotechnology ,Company ,Developing ,Nnovative ,Mall ,Molecules ,End ,Biological ,Nnounced ,Hat ,The ,Ompany 9939 Kyg5273b1077 ,